Introduction {#sec1}
============

Arthritis of the knee is a source of joint pain and stiffness that can be severely debilitating. Total knee arthroplasty (TKA) is an effective treatment and is the current gold standard for providing symptomatic relief and the ability to return to daily activities for patients with end-stage knee arthritis [@bib1], [@bib2], [@bib3].

A better understanding of knee anatomy and biomechanics has resulted in guided motion implants that simulate more natural knee kinematics to improve function [@bib4], [@bib5]. The guided motion knee systems are characterized by anteroposterior stability and physiologic femoral rollback during flexion [@bib6]. Earlier designs sought to replicate natural knee kinematics by implementing asymmetric surface geometry in the medial and lateral condyles as well as an asymmetric cam-post mechanism [@bib7], [@bib8]. JOURNEY Bi-Cruciate Stabilized (BCS) Total Knee System (Smith & Nephew Inc., Memphis, TN) demonstrated axial rotation patterns (posterior translation of the femur and internal rotation of the tibia) during flexion, which resembled that of the normal knee [@bib8]. JOURNEY II BCS is a second-generation model of the JOURNEY BCS system. Published clinical studies of this second-generation system are limited at present to a large series that assessed infections associated with intraarticular injections before TKA using a variety of prostheses [@bib9] and a retrospective study that compared the effect of intraoperative valgus cut angle on postoperative coronal alignment [@bib10]. The aim of this study was to assess the effectiveness and safety of this system at 2 years postimplantation.

Material and methods {#sec2}
====================

We conducted a multicenter case series of consecutive patients. Key inclusion criteria were age ≥18 years with unilateral or bilateral knee disease requiring primary TKA. Patients with a well-functioning contralateral knee arthroplasty were also included. Patients were excluded if there was any other reason for an abnormal gait pattern such as an arthritic hip, a previous hip arthroplasty, a poorly functioning contralateral knee arthroplasty, or a pathologic foot and ankle deformity.

Patients were enrolled at 6 months after the TKA. Baseline operative and perioperative data were collected retrospectively. Six-, 12-, and 24-month data were collected prospectively during the in-clinic visit and included the 2011 version of the Knee Society Score (KSS) [@bib11], radiographic assessments (anteroposterior, lateral and patella views) and treatment complications. The KSS is a validated system that consists of an objective physician component and a patient-reported component. The patient-reported component tracks patient outcomes across 3 dimensions of pain relief, functional abilities, and fulfillment of expectations.

Of 209 enrolled TKAs, 24-month follow-up information was available for 188 (89.95%). The average follow-up time across all TKAs was 23.4 months.

One subject was missing the 6-month KSS and pain evaluations. The missing 12- and 24-month follow-up values for KSS and pain evaluations were imputed using the last-value carry-forward approach.

All participating sites obtained approval from an institutional review board for this research. All patients provided written informed consent. Professional monitors visited the sites to assure that the data are true, accurate, and verifiable.

Statistical analysis {#sec2.1}
--------------------

Descriptive statistical approaches included frequencies and percentages for qualitative variables and means and standard deviations for quantitative variables. Changes in KSS scores and Numeric Pain Rating Scale scores among the follow-up visits were analyzed by one-way repeated measures analysis of variance on imputed data sets. Revision incidence was estimated by Kaplan--Meier estimator [@bib12] and as rate per 100 observed component years.

Results {#sec3}
=======

Overall, 186 subjects (209 knees) were enrolled at 12 sites in the United States, between December 2011 and October 2013. The sites included both academic settings and community practices. Unilateral TKA was performed in 163 subjects (87.6%) and bilateral in 23 subjects (12.4%). Of the 23 bilateral subjects, 11 had the surgeries performed in 1 setting and 12 in a staged approach.

The average age at the index surgery was 61.1 years (standard deviation \[SD\] 7.7 years, range 39-85 years); 52.7% were female. The majority of subjects were Caucasian (169, 90.9%), 8 (4.3%) were Hispanic, 5 (2.7%) were African American, and 4 (2.2%) were Asian. The average body mass index at the time of surgery was 30.4 kg/m^2^ (SD = 4.6; range 16.5-39.9).

Twenty-three of 163 unilateral TKA subjects (14.11%) had a history of TKA on a contralateral knee. One subject had diabetes. Most subjects had unilateral arthritis with no involvement of the contralateral knee (100/160, 53.8%). Fifty subjects (26.9%) received unilateral TKA but had arthritic involvement of the contralateral knee. Charnley class B2 (bilateral TKA) was reported in 33 subjects (17.7%), and 3 subjects (1.6%) were rated as Charnley class C3 ([Table 1](#tbl1){ref-type="table"}). The average surgery time (skin to skin) was 97.7 minutes (SD = 23.4, range 57-214 minutes). The mean length of hospital stay was 2.7 days (SD = 1.6 days, range from 1-15 days, median 2 days).Table 1Distribution of patients by Charnley classification (N = 186).Charnley classificationsA Unilateral knee arthritis100 (53.76%)B1 Unilateral TKA, opposite knee arthritic50 (26.88%)B2 Bilateral TKA33 (17.74%)C1 TKR, but remote arthritis affecting ambulation0C2 TKR, but medical condition affecting ambulation0C3 Unilateral or bilateral TKA of bilateral THR3 (1.61%)[^1]

Average range of motion was 128.3 degrees (SD = 9.6, range 95-153 degrees) at 6-month follow-up and did not change at 12- and 24-month follow-up visits. Owing to the retrospective enrollment of subjects, baseline KSS scores were not available. The average objective KSS improved during the study. At 6-month follow-up, the average objective KSS was 93.74 (SD = 7.36), and at 24-month follow-up it was 96.20 (SD = 6.63) (*P* ≤ .0001) ([Table 2](#tbl2){ref-type="table"}). After the imputation, patient scores were not available for 1 subject. Patient satisfaction score improved from 32.66 (SD = 7.22) at 6-month follow-up to 35.22 (SD = 6.63) at 24-month follow-up (*P* ≤ .0001) ([Table 3](#tbl3){ref-type="table"}). Patient expectation score was 10.39 (SD = 2.93) at 6-month follow-up and 10.91 (SD = 3.16) at 24-month follow-up (*P* = .0394). Functional activities score improved from 75.40 (SD = 13.82) at 6-month follow-up to 81.49 (SD = 14.65) at 24-month follow-up (*P* ≤ .0001) ([Table 3](#tbl3){ref-type="table"}).Table 2Objective KSS Score by follow-up time.Score6 mo (N = 208)12 mo (N = 208)24 mo (N = 208)*P*-valueObjective KSS Score93.74 (7.36)95.31 (6.84)96.20 (6.63)\<.0001 Alignment score24.5 (4.18)24.83 (2.43)24.83 (2.43).3688 Instability score23.99 (2.34)23.85 (2.58)23.89 (2.69).6860 Joint motion score25.57 (2.33)25.92 (2.13)26 (2.08).0009 Symptoms score19.69 (4.37)20.75 (4.36)21.5 (4.07)\<.0001Table 3Patient-reported KSS scores.Score6 mo (N = 185)12 mo (N = 185)24 mo (N = 185)*P*-valueSatisfaction score32.66 (7.22)34.46 (6.62)35.22 (6.63)\<.0001Expectation score10.39 (2.93)10.55 (3.00)10.91 (3.16).0394Functional activities score75.40 (13.82)79.59 (13.13)81.49 (14.65)\<.0001 Walking and standing score24.46 (6.09)26.34 (5.30)26.80 (5.26)\<.0001 Standard activity score24.46 (4.00)25.40 (4.06)25.92 (4.45)\<.0001 Advanced activity score14.00 (5.27)15.39 (5.28)16.05 (5.58)\<.0001 Discretional activity score11.97 (2.78)12.52 (2.55)12.6472 (2.79)\<.0001

There was an improvement in pain between 6- and 24-month postoperatively. Based on a Numeric Pain Rating Scale from 0 to 10, pain level while walking was 1.24 (SD = 1.73) at 6-month postoperatively. This improved to 0.79 (SD = 1.51) at 24-month postoperatively ([Table 4](#tbl4){ref-type="table"}). Pain level while climbing stairs or inclines improved from 2.41 (SD = 2.20) at 6-month postoperatively to 1.50 (SD = 1.97) at 24-month postoperatively. At 6-month follow-up, of the 103 subjects who were employed before the surgery, 93 (90.3%) had returned to work, 4 (3.9%) planned to return to work, and 6 (5.8%) did not return.Table 4Pain level by follow-up.Level of pain6 mo (N = 185)12 mo (N = 185)24 mo (N = 185)*P*-valuePain with level walking1.24 (1.73)1.00 (1.66)0.79 (1.51).0037Pain with stair or inclines2.41 (2.20)1.85 (2.07)1.50 (1.97)\<.0001

Two days after surgery, 1 subject (0.54%) developed a pulmonary embolism. Two subjects (1.07%) developed a deep venous thrombosis, which resulted in a pulmonary embolism in 1 of the subjects at 23 days postoperatively. Radiographic outcomes at 24-month were notable for 1 knee (0.48%), which showed a radiolucency of 2 mm or more in a tibial component. One case of device loosening and possible distal stress fracture was observed at the end of the 2-year follow-up period. There were reports of confirmed postoperative deep infection, at 31 days postoperative that resolved after treatment and at 204 days postoperatively that resulted in revision. One subject (0.54%) developed a postoperative ileus that resolved without sequelae. Two subjects (1.07%) developed Baker\'s cyst, one of which ruptured. Four subjects (2.15%) developed synovitis. Two knees (0.96%) developed iliotibial band syndrome (ITBS); 1 resolved without sequel and 1 was unresolved at 24-month follow-up.

Ten knees (4.8%) were treated with closed manipulations for stiffness. Of these, 7 (3.35%) were performed in 4 subjects (2.15%) who underwent bilateral TKA performed in one setting. Eleven subjects (5.91%) had bilateral TKA performed in one setting. Eleven subjects (5.91%) underwent knee aspiration for swelling and possible infection.

Three subjects (1.61%) underwent revision involving 3 knees (1.43%). One subject (0.54%) developed a deep wound infection which required drainage and replacement of the tibial liner and patella button 8.5 months after the index surgery. Another knee revision was due to a retained bone fragment that necessitated removal of the tibial liner for access and replacement 5 weeks after the index surgery. The third knee revision was performed at 14-month postoperatively due to a mismatched tibial insert implant size (size 4 insert in a size 5 tray). No cases involved revision of tibial or femoral components. The cumulative incidence of revisions at 24-month postoperative was 1.48% (95% confidence interval 0.48%-4.52%) ([Fig. 1](#fig1){ref-type="fig"}). The revision rate was 0.73 (95% confidence interval 0.19-2.00) per 100 observed component years.Figure 1Cumulative incidence of revisions in JOURNEY II BCS implants.

Discussion {#sec4}
==========

Subjects in this study demonstrated favorable objective and subjective outcomes after TKA using the second-generation JOURNEY BCS system. The mean objective KSS increased throughout follow-up intervals. This outcome score assesses knee alignment on anteroposterior radiographs, stability in the anteroposterior and mediolateral planes, joint range of motion, and pain with level-walking or stairs. A similar trend was demonstrated in patient-reported satisfaction, expectations met, and functional activity scores. Postoperative knee flexion at 2 years postoperative reached a mean of 130.5°. The pain scores at 2 years postoperative were low. Most subjects who were employed prior to TKA returned to work. Significant complications included 2 cases of pulmonary embolism, 2 deep infections, and 1 device loosening. There were 3 revisions, none of which involved the tibial or the femoral component.

JOURNEY II BCS is a second-generation JOURNEY BCS total knee system. While many surgeons noted good results with the first-generation system, complications reported included anterolateral and lateral knee pain, ITBS, and posterior cam-post dislocation [@bib13], [@bib14]. Luyckx et al [@bib13] reported a 7.2% rate of ITBS in a consecutive series of over 1000 JOURNEY BCS knees at a mean follow-up of 2.5 years. Despite this complication, the overall survivorship of the first-generation prosthesis was 98%. Sanz-Ruiz et al [@bib15] reported a similar rate of ITBS at 6.6%. In our study, using the second-generation device, the rate of ITBS was 0.96%, suggesting that this complication is less common with the second-generation device.

Digennaro et al [@bib5] compared long-term outcomes in the first-generation system to the Scorpio Non-Restrictive Geometry knee system (Stryker Orthopedics Inc., Mahwah, NJ), a similar but more constrained guided motion prosthesis. The first-generation system treated knees demonstrated significantly better Knee Injury and Osteoarthritis Outcome Scores but had a greater incidence of stiffness. The authors concluded that the greater posterior femoral rollback and physiologic knee kinematics of the first-generation system contributed to better clinical outcomes. In our study, about 1 in 20 knees required closed manipulation for stiffness. Interestingly, a majority of closed manipulations in our study were required for patients who underwent a bilateral TKA during the same surgery.

Another reported complication of the first-generation system was cam-post dislocation. Arnout et al [@bib14] reported 4 such events of 1350 cases (0.3%). In all cases, the knees had an extremely high degree of knee flexion, which allowed the cam to dislocate over the post. There were no cam-post dislocations in our study.

Study limitations included retrospective collection of baseline clinical and operative data. As a result, outcome data could only be trended beginning at the 6-month postoperative time-point after which all subjects were followed prospectively. Inherent to retrospective studies, adverse events and complications during the initial hospital stay may be missed and under reported. However, a strict adherence to the investigational plan was observed and nearly 400 adverse events, most unrelated to the TKA, were captured and reviewed.

Conclusions {#sec5}
===========

In short-term follow-up, the JOURNEY II BCS Guided Motion Total Knee System appears to be a safe and effective device for TKA.
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[^1]: TKR, total knee replacement; THR, total hip replacement.
